Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain)

Freddy A Medina1, Alex W Cohen, Cecilia J de Almeida

  • 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Microbes and Infection
|February 24, 2007
PubMed

Insights

Caveolin-1 (Cav-1) deficiency reduces parasite load in mice infected with T. cruzi, but does not alter mortality. Cav-1 null mice show impaired immune mediator production, suggesting Cav-1

Area of Science:

  • Immunology
  • Parasitology
  • Cell Biology

Background:

  • Host cell caveolae/caveolins are potential targets for pathogens.
  • Caveolin-1 (Cav-1) is a key structural protein in caveolae.

Purpose of the Study:

  • To investigate the role of Cav-1 in Trypanosoma cruzi (T. cruzi) infection.
  • To assess the impact of Cav-1 deficiency on host immune response and disease outcome.

Main Methods:

  • Comparison of T. cruzi infection in Cav-1 null and wild-type mice.
  • Analysis of parasitemia, mortality, cardiac histopathology, and inflammatory mediator levels.
  • Infection of cultured cardiac fibroblasts from both mouse genotypes.

Main Results:

  • 100% mortality in both groups, with slightly delayed death in wild-type mice.
  • Significantly reduced parasitemia in Cav-1 null mice.
  • Similar cardiac pathology but reduced inflammatory mediators (IFN-gamma, TNF-alpha, nitric oxide pathway) in Cav-1 null mice.
  • No difference in cardiac fibroblast infectivity between genotypes.
  • Defective cytokine and chemokine production in Cav-1 null macrophages.

Conclusions:

  • Cav-1 plays a role in modulating the immune response during T. cruzi infection.
  • Despite altered immune mediator production, Cav-1 deficiency does not change the ultimate disease outcome.
  • Cav-1 is important for the normal development of immune responses to T. cruzi.